February 2011 Vol 2, No 1
On behalf of the Academy of Oncology Nurse Navigators (AONN) leadership council, I am excited to introduce the Journal of Oncology Navigation & Survivorship (JONS), a publication designed to meet the needs of oncology nurse and patient navigators.
Lung cancer is the most common type of cancer in the United States.
Maintenance therapy has begun to emerge as a treatment standard for patients with non–small cell lung cancer (NSCLC) whose disease has not progressed after 4 to 6 cycles of frontline chemotherapy.
Improving outcomes for patients with non– small cell lung cancer (NSCLC) is particularly relevant because NSCLC accounts for 85% of all cases of lung cancer.
Significant advances in treating non–small cell lung cancer (NSCLC) have been made over the past 10 years; nevertheless, survival im provement in this disease pales compared with many other solid tumors. Because maintenance chemotherapy offers improved survival in NSCLC, patients and doctors are justifiably excited.
In the first year after a breast cancer diagnosis, women typically experience significant deterioration in their overall quality of life (QOL), but a program that connects new patients with breast cancer survivors following diagnosis seems to halt the decline.
Results 1 - 6 of 6